Agiomix, the largest regional lab for molecular and genetictesting in the Middle East and Africa launched an offering to have staff tested forCOVID-19 in the workplace to reinforce reopening responsibly schemes and helporganizations manage the complexity of this undertaking.

As businesses resume activity, and employees return to the workplace,precautionary hygiene measures, social distancing, ongoing testing and isolationremain crucial in containing the spread of the virus. The organization’s specialistscan visit sites, set up isolation areas and collect samples from employees, providingresults within 48-60 hours. This will assist withidentifying and isolating infectedindividuals, significantly reducing the spread of the virus and at the same timeallowing healthcare providers to deliver the required care to the infected peopleearly enough to help recovery.

As part of its drive to support UAE government initiatives against the pandemic,Agiomix has joined forces with Avivo Group, a collaboration aimed at enhancingaccess of testing to underserved and vulnerable populations working to significantlyreduce the number of infections across the country.

The partnership will catalyze the scientific community to improve COVID-19 testingcapabilities, advancement, and accessibility, offering residents of the UAE at-homeand in the workplace testing services.

Commenting on the partnership,Dr. Salah Al Janabi, Managing Director atAgiomix, said “As businesses begin to reopen, it is imperative to return to workwith the necessary precautions. We will continue to align our efforts to support theDubai Health Authority’s combat efforts against the pandemic. The laboratory hasthe capacity to conduct thousands of tests per day and aimsto test as many peopleas possible in the UAE in collaboration with the authorities in order to contain thepandemic and reduce number of infections. WithDubai and Sharjah governments’decision to resume 100% and 30% of their workforce respectively, we are dedicatedto making a vital contribution to this new normal and support the country’s safereturn to work.

”Dr. Salah Al Janabi, concluded: “As we return to offices, the partnership is key tosupport the UAE authorities’ directive to reopen the country, adhering to thenation’s ‘We Are All Responsible initiative’. The country’s strategy, with early stepstaken to contain the virus and the efforts of the frontline workers has been praisedinternationally. As restrictions continue to ease, with businesses and public spacesopening up, those vulnerable such as the elderly, pregnant women, people with

special needs as well as those with chronic ailments and immune deficiencies, arestill ordered to self-quarantine to ensure health and safety of all. The safety and riskmitigation of the UAE’s employees and residents is of utmost importance and weare prepared to help with the transition to the new reality of a physically distantwork environment.

”Commenting on the partnership, Dr. Atul Aundhekar, CEO of Avivo Group, said,”Agiomix uses the Reverse Transcriptase Polymerase Chain Reaction (rTPCR) test.This test is the gold standard diagnostic tool for COVID-19. Avivo Group has a homecar division and is licensed to send health care workers to residences on call toconduct the test. Many people are scared to venture out, including the elderly,those with children and people of determination for whom driving to a test centercould be difficult. Agiomix is our ideal strategic partner in the UAE during this period.”

Checkout the Press Release